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Abstract
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Gene deletion and protein expression are cornerstone procedures for studying metabolism in any
organism, including methane-producing archaea (methanogens). Methanogens produce coenzymes
and cofactors not found in most bacteria, therefore it is sometimes necessary to express and purify
methanogen proteins from the natural host. Protein expression in the native organism is also useful
when studying post-translational modifications and their effect on gene expression or enzyme
activity. We have created several new suicide plasmids to complement existing genetic tools for
use in the methanogen, Methanosarcina acetivorans. The new plasmids are derived from the
commercially available E. coli plasmid, pNEB193, and cannot replicate autonomously in
methanogens. The designed plasmids facilitate markerless gene deletion, gene transcription,
protein expression, and purification of proteins with cleavable affinity tags from the methanogen,
Methanosarcina acetivorans.

1. Introduction
Genetic methods for Methanosarcina species are well developed, and making mutations on
the chromosome is a routine procedure in several laboratories [1–5]. We sought to increase
the ease-of-use for these tools to facilitate cloning, protein expression, and molecular
biology experiments. The plasmid tools we have created complement existing methods and
expand the repertoire of in vivo experiments possible in methanogens. Of particular need is
the ability to express tagged proteins in methanogens to facilitate protein purification from
the native host.
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Methanogens survive by reducing carbon substrates to methane gas in a process called
methanogenesis [6]. They employ unique enzymes and cofactors to activate carbon for
reduction, and simultaneously generate a transmembrane ion gradient that is used for ATP
synthesis [7, 8]. Unusual cofactors used in methanogens include coenzyme M, coenzyme B,
methanopterins, methanophenazine, dimethylbenzimidazolyl cobamide, and deazaflavin
F420 [9–25]. Because of these unusual cofactors, it may be difficult or impossible to express
some methanogen proteins in heterologous hosts that do not produce these cofactors. If
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cofactor binding is essential for proper protein folding, the absence of the cofactor may
result in misfolded and/or insoluble protein. If the protein does fold properly in a
heterologous host, it is possible that host cofactors may bind in the active site in place of the
native cofactor. For instance, dimethylbenzimidazolyl cobamide is structurally similar,
though not identical to cobalamin [26–28]. The methanogen methanol:corrinoid
methyltransferase, MtaB, and the corrinoid protein, MtaC, from Methanosarcina barkeri,
have been purified from E. coli and biochemically characterized [29–31]. MtaB and MtaC
expressed in E. coli are insoluble, and must be refolded in vitro after purification. As a
result, MtaC is devoid of cofactor and must be reconstituted with the non-native corrin
cofactor, hydroxycobalamin. While heterologously expressed, refolded, and reconstituted
protein can be suitable for biochemical characterization, these treatments introduce the
possibility of producing structural artefacts that can inhibit crystal formation. As such,
overexpression of proteins in the native organism can be desirable to purify soluble protein
populated with the biologically relevant cofactor. The crystal structure of the MtaBC
complex was successfully obtained using protein purified from M. barkeri [32].

Author Manuscript

Dimethylbenzimidazolyl cobamide is not the only exotic cofactor found in methanogens.
Coenzyme F420 is a deazaflavin, and structurally similar to flavin mononucleotide (FMN) in
E. coli [19, 33–36]. To our knowledge, no predicted flavin-binding proteins from
methanogens has been heterologously expressed or crystallized to date. One reason for the
paucity of methanogen flavoprotein structures could perhaps be because annotated flavin
adenine dinucleotide (FAD) or FMN binding sites may in fact be F420 binding sites.
Therefore E. coli flavins may not be able to bind correctly in F420 binding site, resulting in
unstable or misfolded protein. Methanogens also express many proteins with catalytic or
structural iron/sulfur clusters, which do not have homologs in E. coli [37–45]. Therefore,
expression of iron/sulfur cluster proteins in E. coli runs the risk of producing insoluble or
misfolded protein, which may or may not be able to be reconstituted in vitro with Fe2+ and
S2− [46].
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Several methanogen proteins which do not require cofactors have been successfully
expressed from E. coli, such as histone-like proteins, glutamine synthetase GlnK, and
CRISPR Cas6 [47–50]. However, in some circumstances though proteins are not anticipated
to require a cofactor or iron/sulfur cluster, expression of methanogen proteins in E. coli can
still be challenging due to differences in codon usage between the two organisms [51–54].
Codon usage is significantly different between E. coli and methanogens. Translation of
methanogen proteins can be accomplished using E. coli expression strains engineered to
produce rare codons, however the yields can be low [55–57]. The yield of heterologously
expressed methanogen protein can be increased by codon optimizing the nucleotide
sequence for E. coli [55, 57]. Synthesis of codon-optimized genes is more expensive than
traditional cloning involving PCR amplification of the gene of interest. Taking into account
the high proportion of methanogen proteins with iron/sulfur clusters and unique cofactors,
we perceived a need for a wider array of molecular tools for protein expression and
purification in methanogens.
To address the need for plasmids that can be used to express and purify protein from
methanogens, we designed new suicide plasmids based on the features of pMP44 and
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pJK026A [58, 59]. pMP44 is useful for markerless deletion of genes using homologous
recombination [58]. However, pMP44 replicates in the E. coli host at a relatively low-copy
number and must be propagated in a pir+ strain [60, 61]. Plasmid pJK026A and its
derivatives can be used for inserting DNA at a ϕC31 phage att site which has been added to
the chromosome [59]. It is useful for expressing protein in Methanosarcina, or for studying
transcription and translational fusions [2]. pJK026A family plasmids are 11.7 Kb, and must
be purified from a trfA+ E. coli strain [62]. The plasmid sizes, low copy number, and need
for separate E. coli host strains, are attributes that can present technical challenges during
cloning. We wanted to determine if the features of pMP44 and pJK026A could be used to
create smaller plasmids that are suitable for high-copy replication in DH5α or DH10β E. coli
hosts. The new suicide plasmids are designed to 1) use conventional, commercially-available
E. coli hosts, 2) simplify and speed up the cloning process, and 3) combine features in a
multifunctional plasmid that can stably integrate onto the M. acetivorans chromosome and
be used for in vivo protein expression and purification via Strep-Tag II and histidine affinity
tags [63–65].

2. Materials and Methods
2.1 Growth of cultures
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E. coli was grown in Lysis Broth (LB) at 37°C with shaking [66]. M. acetivorans strains
were grown at 35°C in HS medium as described [67]. Table 1 lists all the E. coli and M.
acetivorans strains used in this study. The following additions were added as required (final
concentration): ampicillin (100 µg ml−1), kanamycin (50 µg ml−1), chloramphenicol (8 or 35
µg ml−1), rhamnose (10 mM), histidine (0.1 mM), puromycin (2 µg ml−1), 8-azadiaminopurine (8-ADP) (20 µg ml−1), trimethylamine (50 mM), methanol (125 mM), and
acetate (40 or 120 mM).
2.2 DNA techniques and cloning procedures
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PCR Primers and DNA sequences in Table 2 were designed using Vector NTI software (Life
Technologies Corporation, Grand Island, NY). Genes, oligos, and multiple cloning sites
were synthesized commercially by Integrated DNA Technologies (IDT, Coralville, IA) and
Life Technologies Corporation (Grand Island, NY). Various PCR techniques were employed
during the course of this work, including overlap extension and site-directed mutagenesis
[68, 69]. For all PCR amplifications, Phusion Flash PCR Master Mix was used as a source
of proofreading DNA polymerase (Life Technologies Corporation (Grand Island, NY)).
DNA purification was carried out using Wizard kits from Promega (Madison, WI). DNA
fragments were joined using T4 DNA ligase (New England Biolabs, Ipswich, MA) or
GeneArt kits (Life Technologies Corporation (Grand Island, NY)). Restriction enzymes
(AscI, BamHI, NdeI, NcoI, EcoRI, SphI, XbaI) were purchased from New England Biolabs
(Ipswich, MA). All plasmids were sequenced by Eurofins Operon MWG (Huntsville, AL).
2.3 Transformation
Plasmids used and created in this study are listed in Table 3. E. coli was transformed by
electroporation and plated onto LB agar plates (1.5% w/v agar) containing the appropriate
antibiotic [70]. M. acetivorans was transformed using the liposome-mediated transformation
Plasmid. Author manuscript; available in PMC 2017 March 01.
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method [71]. After transformation and recovery, M. acetivorans cells were plated on HS
medium with 50 mM trimethylamine as carbon source solidified with 1.4% agar and
incubated in Wolfe incubators (Coy Laboratory Products, Grass Lake, MI) under premixed
20% CO2/79.9% N2/0.1% H2S atmosphere (Matheson).
2.4 Western Blot Analysis
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Sample protein concentration was determined using the Coomassie Plus Protein Assay
Reagent (Life Technologies Corporation (Grand Island, NY)). Samples were diluted with 6X
Cracking Buffer (348 mM Tris pH 6.8, 349 mM SDS, 600 mM DTT, 4.1 mM glycerol, 180
µM bromophenol blue), boiled for 10 minutes, and 2 µg each sample were loaded per lane
on a 12% sodium dodecyl sulfate-polyacrylamide gel (Bio-Rad, Hercules, CA). Three
microliters of Precision Plus Protein Dual Color Standards (Bio-Rad, Hercules, CA) and 1.5
µL of Precision Plus Protein WesternC Standards (Bio-Rad, Hercules, CA) were used as
markers. Proteins were separated at 15 mA per gel for 30 minutes and 30 mA per gel for 45
minutes. Proteins were transferred to a polyvinylidene difluoride membrane (PVDF) (BioRad, Hercules, CA) for 1 hour at 100 V in transfer buffer (25 mM Tris, 192 mM glycine,
15% methanol). The membrane was blocked with 25 mL 5% nonfat dry milk in Trisbuffered saline (137 mM NaCl, 20 mM Tris pH 7.6) with 0.1% TWEEN 20 (TBST)
overnight and probed with a 1:4000 dilution of Strep-Tag II Antibody, HRP Conjugate
(Novagen, EMD Millipore, Temecula, CA) in 20 mL of Blocking Solution. Strep-tagged
protein was detected with Pierce ECL Western Blotting Substrate (Life Technologies
Corporation (Grand Island, NY)).
2.5 β-glucuronidase enzyme assays
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Cell extract was assayed for β-glucuronidase activity as described [59]. Briefly, 10 ml
exponential phase cultures of strains listed in Table 1 were harvested by centrifugation in a
TX-750 Swinging Bucket Rotor with 15 mL conical tube adapters at 4031 × g for 3 minutes
at room temperature. Cells were resuspended in 200 µl of 50 mM Tris-Cl, 1 mM DTT pH
8.0 buffer, followed by the addition of 1 u of DNaseI (Life Technologies Corporation (Grand
Island, NY)) and Halt Protease Inhibitor Cocktail, EDTA-Free (Life Technologies
Corporation (Grand Island, NY)) to a final concentration of 1X. Cells were lysed on ice for
10 minutes, and insoluble cell debris was removed by centrifugation in F21–48×1.5/2.0 rotor
at 14000 × g for 10 minutes at room temperature. Cleavage of p-nitrophenyl glucuronide to
p-nitrophenol was detected by increased absorbance at 415 nm in a Tecan Sunrise plate
spectrophotometer (Tecan US, Inc., Morrisville NC). The extinction coefficient of pnitrophenol was determined in Solid 96 Well Plates (Fisher catalog #21-377-205) with a
path length of 0.5 cm at 415 nm. Protein concentration was measured using the Coomassie
Plus Protein Assay Reagent (Life Technologies Corporation (Grand Island, NY)).
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3. Results
3.1 pNB723 plasmid design
We created a high-copy plasmid, pNB723, for markerless deletion of Methanosarcina genes
to circumvent the need to use pir+ E. coli hosts (Figures 1 and S1). To construct pNB723, we
used pNEB193 as the E. coli plasmid scaffold (New England Biolabs, Ipswich, MA).
Plasmid. Author manuscript; available in PMC 2017 March 01.
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pNEB193 is a small, high-copy, commercially available vector with a pUC19 origin of
replication, a bleomycin (ampicillin) resistance cassette, and a PT7 lacZ cassette for bluewhite selection of plasmids containing inserts at the multiple cloning site. To select
Methanosarcina strains which have recombined the plasmid onto the chromosome, we added
the pac (puromycin acetyltransferase) gene at the unique XbaI and SphI restriction sites on
pNEB193. We optimized the pac codons for expression in Methanosarcina, thereby lowering
the %GC content from 73.1% to 48.5%, and eliminating interference in sequencing reactions
that can occur when plasmids contain high %GC stretches (Figure S2). The optimized pac
gene was amplified from pMS86 using oligos oNB115 and oNB116, which added a XbaI
restriction site at the 5’ end of the gene, and tandem SpeI and SphI restriction sites at the 3’
end of the gene. The resulting plasmid carrying a promotorless optimized pac gene is
pNB721.
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The Methanococcus voltae PmcrB promoter from pMP44 was cloned upstream of the pac
gene at the XbaI restriction site, creating plasmid pNB722. The PmcrB(M. voltae) promoter
will constitutively express the pac gene in Methanosarcinales. PmcrB(M. voltae) was cloned
from pMP44 using oligos oNB128 and oNB129, which added XbaI sites at each end of the
gene. Orientation of the promoter was verified by DNA sequencing to ensure that the pac
gene will be expressed in the host strain.
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Finally, we cloned a hypoxanthine phosphoribosyltransferase gene (hpt) at the SpeI and SphI
restriction sites in pNB722 so that the resulting plasmid, pNB723, expresses the hpt gene in
an operon with the pac gene. The hpt gene is a counterselection marker that can be used to
create a markerless gene deletion when transformants are plated on the purine analog, 8-azadiaminopurine (8-ADP) [58]. The hpt gene was also codon-optimized for expression in
Methanosarcina, which resulted in lowering the %GC content from 47.6% to 36.7% (Figure
S3). The optimized hpt gene was amplified from pMS66 using oligos oNB106 and oNB127,
which added a XbaI site at the 5’ and at the 3’ ends of the gene. Directionality of the hpt
gene was verified by DNA sequencing. The resulting pNB723 plasmid has unique NdeI and
BamHI sites, and two AscI restriction sites, which can be used to clone DNA sequences for
deletion of genes in Methanosarcina.
3.2 Deletion of MA4421 using pNB723
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To demonstrate that pNB723 functions as designed, we used it to delete the MA4421 prenyl
reductase gene from the M. acetivorans chromosome (Figure 2). For the plasmid validation
purposes here, the gene to be deleted was expected to be nonessential. The DNA sequence 5’
upstream of the MA4421 gene was amplified using primers oNB250 and oNB252. The 3’
downstream DNA sequence was amplified using primers oNB251 and oNB253. The 5’ and
3’ sequences were fused using oligos oNB311 and oNB312, and cloned into the pNB723
plasmid at the AscI restriction site, resulting in plasmid pALD1 (Figure S4). Plasmid
pALD1 was transformed into M. acetivorans strain NB34 using liposomes, and puromycin
as a selection agent. The puromycin-resistant colonies were streaked for isolation, grown in
liquid medium without puromycin, and plated onto agar containing 8-ADP to counterselect
for the hpt gene. The resulting 8-ADP-resistant colonies were streaked for isolation, and
grown in liquid medium without puromycin or 8-ADP. Markerless deletion of the MA4421
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gene was confirmed by PCR amplifying the MA4421 deletion junctions from genomic DNA
using the oNB274, oNB318 and oNB319 oligos (Figure 2). In this PCR strategy, the
screening oligos do not anneal to the 5’ upstream or 3’ downstream DNA sequences that
were used to construct the pALD1 deletion plasmid. Methanosarcina cells can carry several
copies of the chromosome, and PCR amplification for the deleted gene is essential to ensure
that all copies of the gene have been deleted [72]. In addition, plasmids may integrate in
unpredictable ways if there is a region of low complexity or if the gene is essential.
Surviving cells may, for instance, create large deletions, amplifications, or insertions to
preserve essential gene function while also generating a false-positive in a PCR screen. As
additional measures to confirm strain identity, genome resequencing and/or Southern blots
using probes specific for the deleted gene, for flanking genomic regions, or for pac or bla (to
verify plasmid insertion at the expected location) is also indicated (Figure S5).
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3.3 pNB730 plasmid design
We created a pNEB193-derived plasmid for expression of tagged protein in Methanosarcina.
Using oligos oNB151 and oNB152, we removed the SpeI restriction site, creating plasmid
pNB724. pNB724 was amplified using oligos oNB110 and oNB111, which creates SpeI
restriction sites at the 5’ and 3’ ends of the linear amplification product. To insert the ϕC31
phage attB attachment site that allows the plasmid to recombine with the ϕC31 attP site on
the M. acetivorans NB34 chromosome, we amplified the ϕC31 phage attB site from
pJK026A using oligos oNB117 and oNB118, which creates XbaI restriction sites at the 5’
and 3’ ends of the amplification product. The XbaI-digested attB fragment was ligated into
the SpeI-digested pNB724 amplicon to create pNB727. pNB727 was verified by DNA
sequencing.
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Next, we designed an expression cassette with multiple restriction sites to facilitate cloning
(Figure 3). The cassette, encoded on plasmid pNB716, contains the PmcrB promoter from
pJK026A and a multiple cloning site (MCS) flanked by sequences encoding the Strep-Tag II
peptide (strep, WSHPQFEK) and histidine tags (his, HHHHHHHH). The Strep-Tag II
peptide was codon optimized for expression in M. acetivorans (Figure 3, orange shaded
sequences). The 5’ and 3’ tag sequences were not identical so as to prevent homologous
recombination that would result in loss of the MCS or of the gene to be expressed. The
expression cassette was designed such that cloning a gene into the NdeI site results in
expression of native protein. Cloning the gene into the NcoI site results in protein with an
amino-terminal his-strep tag. Carboxy-tagged protein can be expressed by removing the stop
codon from the gene and cloning into the BamHI, ApaI, or NruI restriction sites. Therefore
this expression cassette can be used to express native, amino-tagged, carboxy-tagged, or
dual-tagged protein depending on the restriction sites used. A strong translational stop signal
was added after the 3’ his-strep tag sequence by introducing four stop codons within a 20 bp
region. The expression cassette was amplified from pNB716 using oligos oNB183 and
oNB184 and digested with XbaI restriction enzyme.
pNB727 was amplified using oligos oNB130 and oNB131, resulting in a linearized
amplicon containing SpeI restriction sites at the 5’ and 3’ termini. The pNB727 amplicon
was digested with SpeI, then ligated with the XbaI-digested expression cassette from
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pNB716, to create the plasmid pNB729. Finally, oligos oNB185 and oNB186 were used to
amplify pNB729 and remove the BamHI restriction site upstream of the pac expression
cassette. The resulting plasmid, pNB730, contains unique NdeI, NcoI, BamHI, ApaI, and
NruI restriction sites for cloning genes into the expression cassette multiple cloning site.
pNB730 was verified by DNA sequencing (Figure S6).
3.4 Native and tagged expression of uidA using pNB730
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We used the β-glucuronidase (uidA) gene to measure tagged and untagged protein
expression in M. acetivorans from the expression cassette we created (Figure 4). The uidA
gene was amplified from pJK026A using oligos oNB369 and oNB371 and cloned into the
NdeI and BamHI sites of pNB730 to create plasmid pSK1 (expresses native UidA) (Figure
S7). The uidA gene was also amplified from pJK026A using oligos oNB370 and oNB372,
and cloned into the NcoI and BamHI sites to create plasmid pSK2 (expresses dual-tagged
UidA) (Figure S8). Plasmids pSK1 and pSK2 were transformed into M. acetivorans strain
NB34. Cells which had recombined the plasmid onto the chromosome at the ϕC31 attP site
were selected using puromycin. Puromycin-resistant colonies were streaked for isolation,
grown in liquid medium without antibiotic, and screened by PCR.
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To screen for integration at the attP site, oligos “C31 screen-all#1”, “C31 screen C2A #1”,
“C31 screen pJK200#1”, and oNB317 were used in a four-oligo PCR reaction with genomic
DNA [59]. In this four-oligo PCR amplification, genomic DNA from strains which have
integrated a single copy of pNB730-derived plasmids will produce amplicons of 740 and
471 bp. A 301bp band is amplified by plasmid alone or if multiple copies of the pNB730derived plasmid has integrated at the ϕC31 attP site. Parental genomic DNA template will
result in amplification of a 910 bp fragment. Using this screen, we verified the creation of
strains NB231 (Δhpt::ϕC31 int, att:pSK1) and NB232 (Δhpt::ϕC31 int, att:pSK2), which had
recombined the respective plasmid at the ϕC31 attP site on the chromosome. Plasmid
integration was also confirmed by Southern blot using the uidA gene as a probe (Figure S9).

Author Manuscript

Next, we verified expression of UidA enzyme from the integrated pSK1 or pSK2 plasmids
(Figure 4). To verify expression of tagged protein, we analyzed cell extract from strains
NB231 (att:pSK1), NB232 (att:pSK2) by Western blot using anti-strep-tag antibodies. The
parent extract was used as a negative control, and the positive control was cell extract from
strain NB75, which expresses strepHdrD2 (37 kDa) from an integrated copy of the
pJK026A-derived plasmid, pNB665. The cell extract from strains that expressed tagged
protein had a single strep-tagged protein band at the expected size of 71 kDa, whereas the
parent extract and NB231 (att:pSK1, which expresses untagged UidA protein), had no
visible bands. We also added 0.1 mM histidine to cultures to determine if adding exogenous
histidine to the medium could increase expression of his-tagged protein. It would be
reasonable to hypothesize that methanogens may produce limiting quantities histidine to
synthesize large quantities of a his-tagged protein. Histidine supplementation, assuming it
could be transported into the cell and used to charge histinyl tRNAs, may alleviate this
limitation and result in higher expression levels. However, addition of histidine had no
measurable effect on protein expression. Finally, we verified that the UidA protein expressed
from pNB730 was properly folded and active. As expected, cell extract from strains NB231
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(att:pSK1, expresses untagged protein) and NB232 (att:pSK2, expresses dual-tagged
protein) had detectable β-glucuronidase activity, whereas extract from the parent strain had
no detectable β-glucuronidase activity (Figure 4). We noted that activity of untagged βglucuronidase (pSK1) is higher than the dual-tagged β-glucuronidase (pSK2), demonstrating
that amino and/or carboxy-terminal peptide tags can affect enzyme function and may not
reflect differences in translation efficiency from identical promoters.
3.5 Creation of plasmids for expression of protein with cleavable affinity tags
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In some circumstances (i.e., if it interferes with enzyme activity, or for protein
crystallography) it may be preferable to have the ability to cleave affinity tags from
expressed protein. Therefore we designed two additional plasmids based on pNB730, which
include thrombin cleavage sites (Figure 2). The thrombin recognition site (LVPRGS) was
optimized for expression in M. acetivorans [73, 74]. Plasmid pNB735 has the thrombin site
immediately downstream of the 5’ strep-tag and histidine tag, before the NcoI site where a
gene of interest can be cloned. The complementary plasmid, pNB737, was created to express
proteins with a thrombin-cleavable amino-terminal his tag. The sequences of both plasmids,
pNB735 (Figure S10) and pNB737 (Figure S11), have been verified by DNA sequencing.

4. Discussion
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We have succeeded in creating a suite of easy-to-use plasmids for gene deletion and
expression of affinity tagged protein in Methanosarcina acetivorans. We have also
demonstrated the utility of these plasmids in deleting genes from the chromosome
(MA4421), and in expressing active enzymes in vivo. Depending on the restriction sites used
for insertion of the gene of interest, the expressed protein either contains Strep-Tag II and
histidine affinity tags or is untagged. The small, high-copy plasmids are compatible with
ligation-independent cloning methods such as GeneArt Seamless Cloning and Assembly
Kits (Invitrogen). The ease of propagation in E. coli, and the ease of cloning make the
pNB723 and pNB730 family plasmids compatible with modern synthetic biology
experiments. Though not demonstrated in this work,, plasmid pNB730 can be used for a
wide array of experiments including mutant complementation, purification of proteins to
study post-translational modification, and metabolic engineering applications in addition to
expression of foreign proteins in the cell [75–77].
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pNB735 and pNB737 plasmids will also make it easier to express protein in Methanosarcina
for purification and crystallography purposes. To advance methanogen structure/function
studies, we anticipate plasmid tools designed specifically for protein purification in
methanogens, such as pNB735 and pNB737, may make it possible to obtain large quantities
of pure, correctly folded protein from the native organism. Purification of protein from the
native host may enable correct protein folding and population of the active site with the
physiological cofactor. After purification, affinity tags can be removed by digestion with
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thrombin protease. The pNEB193-derived plasmids we created add to the expanding
repertoire of genetic and protein expression tools in M. acetivorans and other
Methanosarcina species [5, 58, 59, 78, 79].
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The multiple cloning site we designed for pNB730 and derivative plasmids contained a UAG
stop codon to terminate translation of the carboxy-terminal his-strep affinity tag. In
Methanosarcina, UAG can either be translated as a pyrrolysine residue, or will be recognized
as a termination signal, depending on whether a PYLIS element is encoded in the 3’
untranslated region of the RNA. When a PYLIS element is absent, approximately 70% of
the translated polypeptides will stop at the UAG, while 30% of the time pyrrolysine will be
incorporated into the growing protein chain, and translation continues until a second UAA or
UGA stop codon is encountered. In the pNB730 multiple cloning site, the next in-frame stop
codon is 336 bp downstream. If pyrrolysine had been incorporated in the uidA translation
product, we would expect to detect two bands, one at 71 kDa, and the pyrrolysine readthrough product at 83 kDa. In anti-strep immunoblots we only detected a single band at 71
kDa, indicating that translation was terminated at the first UAG codon. Kryzcki and
coworkers noted that in highly expressed monomethylamine methyltransferase genes, the +1
and +2 nucleotides after the pyrrolysine-coding UAG codon are often GG [80]. Others have
observed that the efficiency of pyl incorporation at UAG codons in heterologous systems can
vary with the gene context [81, 82]. This contextual dependence on translational termination
has been described in eukarya [83]. Our data suggests that the +1 and +2 nucleotides after
the stop codon, TT, may disfavor pyrrolysine incorporation and instead results in translation
termination in methanogens.

5. Conclusions
Author Manuscript

Methanogenic archaea produce several unusual coenzymes and cofactors that are not
synthesized by E. coli, thereby constraining the ability to use E. coli as a heterologous host
for overexpression and purification of a subset of methanogen proteins. To address this
limitation, we have created a suite of plasmids for gene deletion and protein overexpression
in Methanosarcina species. The new plasmids are derived from the small, high-copy E. coli
plasmid, pNEB193, and can be propagated in standard E. coli cloning strains. We have
successfully used the new plasmids to overexpress a native or his-strep tagged βglucuronidase and to delete the gene MA4421 from the chromosome. These plasmids
complement the growing list of genetic tools available for studying methanogen biology, and
will be especially useful for identifying post-translational modifications in methanogen
proteins, and for expressing proteins with amino- or carboxy-terminal affinity tags that can
be cleaved with thrombin.
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Highlights
•

We have created a suite of user-friendly plasmids for methanogens.

•

The new plasmids are now compatible with ligation-independent cloning.

•

We validated plasmids for markerless gene deletion

•

Plasmids were used to express a native and his-tagged reporter gene.
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Figure 1.

pNB723 and pNB730 plasmid maps. Genes encoding puromycin acetyltransferase (pac, red)
and hypoxanthine phosphoribosyltransferase (hpt, green) are codon-optimized for
expression in Methanosarcina.
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Figure 2.

Author Manuscript

Deletion of MA4421 from the chromosome using pALD1. Schematics of the MA4421
genomic locus in the parental strain (A), and in the deletion mutant (B), are shown. (C) PCR
results with oligos oNB274 and oNB319 showing deletion of MA4421 in two isogenic
isolates. Gray box= MA4421 coding sequence. White boxes= DNA sequences upstream
(“up”) and downstream (“down”) of the MA4421 gene that were used to create plasmid
pALD1. Open arrowheads= annealing site of PCR oligos used to construct pALD1. Solid
arrowheads= annealing site of PCR oligos used to screen for deletion of MA4421 on the
chromosome. M= DNA size marker. Kb= kilobasepairs. The asterisks denote the expected
amplicon sizes.
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Multiple cloning sites of pNEB193-derived plasmids used for protein expression in
Methanosarcina. The ribosome binding site is in bold font. Unique restriction sites are
underlined. Green triangle= translation start site. Red square= stop codon. Orange box=
Strep-Tag II sequence. Blue box= histidine tag sequence. Gray box= thrombin recognition
sequence.
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Expression of tagged UidA protein in M. acetivorans. (A) Verification of integration of
pSK1 and pSK2 on the chromosome. Genomic DNA from four isolates of each
transformation were screened by PCR. M= marker. (B) Western blot of strep-his-UidA-hisstrep protein expressed in M. acetivorans. Two micrograms of total protein from each strain
were separated by denaturing PAGE. Western blots were probed with anti-strep antibodies.
His= cultures were supplemented with 0.1 mM histidine. (C) Triplicate cultures of each
strain were assayed in triplicate (N=9). Specific activity reported in nmoles min−1 mg−1
lysate.
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Table 1

Author Manuscript

Strains used in this study
NB#

Genotype

Purpose

Reference

E. coli strains

Author Manuscript

NB3

5α F' lacIq

parent

New England Biolabs

NB4

10β

parent

New England Biolabs

NB100

10β/pNB721

Promotorless pac (opt) for conditional essentiality test of promoters in
M. acetivorans

This study

NB101

10β/pNB722

pac (opt) vector for homologous recombination repair of mutants, gene
deletion by homologous recombination (marked) in M. acetivorans

This study

NB104

5α F' lacIq/pNB723

Gene deletion by homologous recombination (markerless) in M.
acetivorans

This study

NB128

5α F' lacIq/pNB724

pac (opt) vector for homologous recombination repair of mutants, gene
deletion by homologous recombination (marked) (unique SpeI restriction
site) in M. acetivorans

This study

NB131

5α F' lacIq/pNB727

operon insertion into ϕC31 attP site on the chromosome in M.
acetivorans

This study

NB133

5α F' lacIq/pNB729

Expression of native or tagged protein in M. acetivorans

This study

NB134

5α F' lacIq/pNB730

Expression of native or tagged protein (unique BamHI restriction site) in

This study

M. acetivorans
NB161

5α F' lacIq/pALD1

MA4421 deletion by homologous recombination (markerless) in M.
acetivorans

This study

NB224

5α F' lacIq/pSK1

Expresses native UidA in M. acetivorans

This study

NB225

5α F' lacIq/pSK2

Expresses strep-his-UidA-his-strep protein in M. acetivorans

This study

NB238

10β / pNB735

Expresses native or tagged protein in M. acetivorans. Amino-terminal
strep-his tag is cleavable with thrombin protease.

This study

NB239

10β/ pNB737

Expresses native or tagged protein in M. acetivorans. Amino-terminal his
tag is cleavable with thrombin protease.

This study

Author Manuscript

M. acetivorans strains
NB34

Δhpt::ϕC31 int, attP

parent

[59]

NB218

Δhpt::ϕC31 int, attP, ΔMA4421

ΔMA4421 mutant

This study

NB231

Δhpt::ϕC31 int, att:pSK1

Expresses native UidA protein

This study

NB232

Δhpt::ϕC31 int, att:pSK2

Expresses strep-his-UidA-his-strep tagged protein

This study

Author Manuscript
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Table 2

Author Manuscript

Sequences of DNA synthesized in this study
Purpose

Name

Sequence (5’-3’)

Reference

Amplify pac (opt) gene from
pMS86

oNB115

TCTAGAGTGATTCTCATGACCGAATATAAAC

This study

oNB116

GCATGCACTAGTTCATGCTCCAGGTTTCCTG

This study

Amplify PmcrB(M. voltae) from
pMP44

oNB128

ACTAGTCGGTTTGCGTATTGGCG

This study

oNB129

ACTAGTTCCTATTTTTTTGATATATACATCATAACA

This study

Amplify hpt (opt) from pMS66

oNB106

TCTAGATCACTGATTTCCAAAAACATCTTTAATCTCAACTCC

This study

oNB127

TCTAGACATGGTTGAAAGGCTTAAAGATTCCC

This study

oNB151

GCATGCAAGCTTGGCGTAATCATG

This study

oNB152

GCATGCTCATGCTCCAGGTTTCC

This study

oNB117

TCTAGAATGAATCAACAACTCTCCTGGCGCA

This study

oNB118

TCTAGACGCTGGCGATTCAGGTTCATCATG

This study

oNB110

ACTAGTCTTGTCTGCTCCCGGCATCCG

This study

oNB111

ACTAGTCCCGTCAGGGCGCGTCA

This study

oNB130

ACTAGTGGTGTGAAATACCGCACAGATGCGTAA

This study

oNB131

ACTAGTTGACGCGCCCTGACGGG

This study

oNB183, M13 forward
- 20

GTGTAAAACGACGGCCAGTTTATCTAGTCA

Integrated
DNA
Technolog
ies (IDT)

oNB184, M13 reverse
-27

CCTCAGGAAACAGCTATGACATCAAGCT

Integrated
DNA
Technolog
ies (IDT)

oNB185

GGGGGCGCGCCGGATCTTAATTAAGTCTAG

This study

oNB186

CTAGACTTAATTAAGATCCGGCGCGCCCCC

This study

oNB250

AAAAAAAAAAAAGGCGCGCCCTGGATTTTTTACAGATTCTAATGATTCCAGG

This study

oNB251

GCTCTGCATATATCTTGGATCTTATACCCCATGCTGAACTACAGAACGTT

This study

oNB252

AACGTTCTGTAGTTCAGCATGGGGTATAAGATCCAAGATATATGCAGAGC

This study

oNB253

AAAAAAAAAAAAGGCGCGCCCCTGCCCCTCACATAATCGTGC

This study

oNB311

GCCCTGGTTTGGTTCCCGGTTTACCAGAGAATGGAGGTATAAGATCCAAGAT

This study

oNB312

ATCTTGGATCTTATACCTCCATTCTCTGGTAAACCGGGAACCAAACCAGGGC

This study

oNB274

GACCTTCTGGTGGATTGTTG

This study

oNB318

GCAAAGCTTGTATACAGGGCAG

This study

oNB319

CTCGGAAGCATGGTCTATCC

This study

oNB369

CATATGTTACGTCCTGTAGAAACCCCAACCCG

This study

oNB370

CCATGGTACGTCCTGTAGAAACCCCAACCCG

This study

oNB371

GGATCCTCATTGTTTGCCTCCCTGCTGCGG

This study

oNB372

GGATCCTTTTGTTTGCCTCCCTGCTGCGGTT

This study

oNB301

GGCTGGCTTAACTATGCGGCATC

This study

oNB302

GCACCGTGGGTTTATATTCGGTCATGAGAATC

This study

Removes SpeI restriction site from
pNB722
Amplify ϕC31 attB from
pJK026A

Author Manuscript

Amplify entire pNB724

Amplify entire pNB727

Amplify expression cassette from
pNB716 (inserts in pIDTSmartAmp)

Removes second BamHI site from
pNB729

Author Manuscript

Creation of MA4421 deletion
fusion fragment

Amplifies MA4421 chromosomal
region

Amplifies uidA from pJK026A

Author Manuscript

pNB723 insert sequencing
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Author Manuscript

Purpose

Name

Sequence (5’-3’)

Reference

pNB730 MCS insert sequencing

oNB303

CGTCAGGGCGCGTCATTAACTACT

This study

att integration of pNB730 at the
hpt locus

ϕC31 screenall#1

GAAGCTTCCCCTTGACCAAT

[59]

ϕC31 screen-C2A#1

TTGATTCGGATACCCTGAGC

[59]

ϕC31 screen- pJK200#1

GCAAAGAAAAGCCAGTATGGA

[59]

oNB317

GATGAGTGGCAGGGCGGGGCGTAAT

This study

Strep-His-Thrombin

ATTAAGGAGGAAATTCATATG
TGGAGCCACCCTCAGTTCGAGA
AACA TCACCATCACCATCATCA
CCATCTGGTGCCGCGTGGCTCT
TCCATGGAAGGCGCGCCGGA TC
CAAGCTTGGGCCCTCG

This study

His-Thrombin

ATTAAGGAGGAAATTCATATGC
ATCACCATCACCATCATCACCA
TCT GGTGCCGCGTGGCTCTTCC
ATGGAAGGCGCGCCGGATCCA
AGCTTGGGCCCTCG

This study

Thrombin-cleavable tagged protein

Author Manuscript
Author Manuscript
Author Manuscript
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Table 3

Author Manuscript

Plasmids used in this study
Name
pNEB193

Features

pUC19 ori,

bla +,

bla+,

lacZ+

Purpose

Reference

Parent vector

New England Biolabs

Gene deletion by homologous recombination
(markerless)

[58]

pMP44

oriR6K,

pJK026A

oriV, repE, sopABC, cat, ϕC31 attB, Pmcr (M. voltae)
pac-hpt, PmcrB uidA

Gene insertion into ϕC31 attP site on the
chromosome

[59]

pMS86

pac (opt)

synthesized

This study

pMS66

hpt (opt)

synthesized

This study

pNB716

strep-his MCS his-strep expression cassette

synthesized

This study

Promotorless pac (opt) for conditional
essentiality test of promoters in M. acetivorans

This study

Pmcr (M. barkeri) hpt, Pmcr (M. voltae) pac

bla +,

lacZ+,

Author Manuscript
Author Manuscript

pNB721

pUC19 ori,

pNB722

pUC19 ori, bla +, lacZ+, PmcrB(M. voltae) pac (opt)

pac (opt) vector for homologous recombination
repair of mutants, KO by homologous
recombination (marked) in M. acetivorans

This study

pNB723

pUC19 ori, bla +, lacZ+, Pmcr (M. voltae) pac- hpt

Gene deletion by homologous recombination
(markerless) in M. acetivorans

This study

pNB724

pUC19 ori, bla +, lacZ+, PmcrB(M. voltae) pac (opt)

pac (opt) vector for homologous recombination
repair of mutants, gene deletion by homologous
recombination (marked) (unique SpeI restriction
site) in M. acetivorans

This study

pNB727

pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae)
pac (opt)

operon insertion into ϕC31 attP site on the
chromosome

This study

pNB729

pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae)
pac (opt), strep-his MCS his-strep expression
cassette

Expression of native or tagged protein in M.
acetivorans

This study

pNB730

pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae)
pac (opt), strep-his MCS his-strep expression
cassette

Expression of native or tagged protein (unique
BamHI restriction site) in M. acetivorans

This study

pALD1

pUC19 ori, bla +, lacZ+, PmcrB(M. voltae) pac- hpt,
ΔMA4421 deletion fusion

MA4421 deletion by homologous recombination
(markerless) in M. acetivorans

This study

pSK1

pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae)
pac (opt), uidA

Expresses native UidA in M. acetivorans

This study

pSK2

pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae)
pac (opt), strep-his- uidA-his-strep

Expresses strep-his-UidA-his-strep protein in M.
acetivorans

This study

pNB735

pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae)
pac (opt), strep-his (thrombin) MCS his-strep
expression cassette

Expression of native or tagged protein in M.
acetivorans. Amino-terminal strep-his tag is
cleavable with thrombin protease.

This study

pNB737

pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae)
pac (opt), his (thrombin) MCS his-strep expression
cassette

Expression of native or tagged protein in M.
acetivorans. Amino-terminal his tag is cleavable
with thrombin protease.

This study

pac (opt)

Author Manuscript
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